Biosana Pharma

Biosana Pharma possesses a technology platform aimed at tackling the exorbitant Costs of Goods in order to enhance the affordability and accessibility of biopharmaceuticals; the 3C production platform enables a reduction in manufacturing expenses by 90%. Situated in Leiden (The Netherlands), as well as in Singapore and Sydney (Australia), Biosana Pharma is leveraging our innovative continuous process to develop a distinctive and highly competitive product portfolio of mAb biosimilars.